Skip to main content
Equibles

PNC FINANCIAL SERVICES GROUP, INC.

Position in AVXL — Anavex Life Sciences Corp.

CIK 713676 Pittsburgh, PA
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$172,550
-$18,072 QoQ
Shares Held
66,622
+7.3% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 179 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PNC FINANCIAL SERVICES GROUP, INC. holds $113,432,736 across 262 Biotechnology names. AVXL ranks #60 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 69,358 $34,452,195
2 REGN
Regeneron Pharmaceuticals, Inc.
 16,662 $10,389,420
3 TECH
BIO-TECHNE Corp
 77,074 $5,445,277
4 MRNA
Moderna, Inc.
 70,829 $4,960,151
5 TGTX
Tg Therapeutics, Inc.
 89,646 $4,925,149
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 39,473 $3,847,827
7 INCY
Incyte Corp
 32,777 $3,715,597
8 ARGX
Argenx SE
 3,967 $3,680,460

All Filings in AVXL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $172,550 66,622
2026-03-31 $190,622 62,092
2025-12-31 $226,725 63,687
2025-09-30 $569,848 64,028
2025-06-30 $585,570 63,511
2025-03-31 $494,832 57,673
2024-12-31 $512,372 47,707
2024-09-30 $270,974 47,707
2024-06-30 $165,874 39,307
2024-03-31 $116,835 22,954
2023-12-31 $165,083 17,732
2023-09-30 $114,310 17,452
2023-06-30 $152,144 18,714
2023-03-31 $149,563 17,452
2022-12-31 $143,085 15,452
2022-09-30 $138,824 13,452
2022-06-30 $74,594 7,452
2022-03-31 $36,117 2,934
2021-12-31 $42,517 2,452
2021-09-30 $35,900 2,000
2021-06-30 $45,720 2,000